Aminosalicylate class drugs
13 results
Balsalazide disodium (balsalazide disodium)
(Balsalazide Disodium)Hikma Pharmaceuticals USA Inc.
Usage: Balsalazide disodium capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients aged 5 years and older. Safety and effectiveness beyond specified durations (8 weeks for pediatric and 12 weeks for adults) have not been established.
Canasa (mesalamine)
(Mesalamine)Allergan, Inc.
Usage: CANASA is indicated for the treatment of mildly to moderately active ulcerative proctitis in adults.
Delzicol (mesalamine)
(mesalamine)A-S Medication Solutions
Usage: DELZICOL is indicated for the treatment of mildly to moderately active ulcerative colitis in patients aged 5 and older, as well as for the maintenance of remission of ulcerative colitis in adults.
Mesalamine (mesalamine)
(Mesalamine)Zydus Lifesciences Limited
Mesalamine (mesalamine)
(MESALAMINE)Alembic Pharmaceuticals Inc.
Usage: Mesalamine extended-release capsules are indicated for maintaining remission in adults with ulcerative colitis.
Mesalamine (mesalamine)
(mesalamine)Zydus Pharmaceuticals (USA) Inc.
Usage: Mesalamine delayed-release tablets are indicated for the treatment of moderately active ulcerative colitis in adults. The safety and effectiveness for use beyond 6 weeks have not been established.
Mesalamine (mesalamine)
(mesalamine)Zydus Lifesciences Limited
Mesalamine (mesalamine)
(mesalamine)Zydus Lifesciences Limited
Mesalamine (mesalamine)
(Mesalamine)AvKARE
Usage: Mesalamine delayed-release tablets are indicated for treating moderately active ulcerative colitis in adults. Their safety and effectiveness have not been established beyond 6 weeks of use.
Mesalamine (mesalamine)
(Mesalamine)Zydus Lifesciences Limited